Jefferies & Company Maintains Regeneron Pharmaceuticals at Buy, Raises PT from $161 to $179
Tickers: REGN
Get News First. Profit Faster
With Benzinga Professional get unlimited access to ALL content! PLUS:
- REALTIME NEWSFEED
- REALTIME AUDIO NEWS
- FULL CALENDAR SUITE
- CHAT WITH OUR NEWS DESK
RECENT PRO ALERTS
US Says Japan Should Refrain from Competitive Devaluation
04:22pm - April 12, 2013Jefferies Suspends Buy Rating on DynaVox Inc., Removes $2.00 PT
04:17pm - April 12, 2013Cowen Securities Suspends Buy Rating on Tsakos Energy Navigation Ltd, Removes $7.50 PT
04:17pm - April 12, 2013
Posted in: Price Target, Analyst Ratings
Partner Network